Your browser doesn't support javascript.
loading
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization.
Dey, Souvik; Mondal, Arpita; DuHadaway, James B; Sutanto-Ward, Erika; Laury-Kleintop, Lisa D; Thomas, Sunil; Prendergast, George C; Mandik-Nayak, Laura; Muller, Alexander J.
Afiliación
  • Dey S; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Mondal A; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • DuHadaway JB; Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Sutanto-Ward E; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Laury-Kleintop LD; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Thomas S; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Mandik-Nayak L; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Muller AJ; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer Immunol Res ; 9(5): 514-528, 2021 05.
Article en En | MEDLINE | ID: mdl-33622713

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Interferón gamma / Proteínas Serina-Treonina Quinasas / Indolamina-Pirrol 2,3,-Dioxigenasa / Inflamación / Neovascularización Patológica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Interferón gamma / Proteínas Serina-Treonina Quinasas / Indolamina-Pirrol 2,3,-Dioxigenasa / Inflamación / Neovascularización Patológica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos